Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001225208-15-016229)

Filing Details

Accession Number:: 0001225208-15-016229
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-08-03 07:24:31
Reporting Period:: 2015-07-30

Filing Date:: 2015-08-03
Accepted Time:: 2015-08-03 07:24:31
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
78003	Pfizer Inc	PFE	Pharmaceutical Preparations (2834)	135315170

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1174449	V Loretta Cangialosi	Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017	Sr. Vice President, Controller	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-07-30	102	$35.67	199,213	No	4	S	Direct
Common Stock	Disposition	2015-07-30	400	$35.69	198,813	No	4	S	Direct
Common Stock	Disposition	2015-07-30	1,598	$35.68	197,215	No	4	S	Direct
Common Stock	Disposition	2015-07-30	1,600	$35.62	195,615	No	4	S	Direct
Common Stock	Disposition	2015-07-30	3,200	$35.65	192,415	No	4	S	Direct
Common Stock	Disposition	2015-07-30	4,604	$35.64	187,811	No	4	S	Direct
Common Stock	Disposition	2015-07-30	5,200	$35.63	182,611	No	4	S	Direct
Common Stock	Disposition	2015-07-30	8,000	$35.66	174,611	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	680	Indirect	By Rule 16b-3 Plan